Litcius/Paper detail

FDG PET/CT in a Patient With Mantle Cell Lymphoma and COVID-19

Margot Playe, Justine Siavellis, Thorsten Braun, Michaël Soussan

2020Clinical Nuclear Medicine10 citationsDOIOpen Access PDF

Abstract

A 52-year-old woman with no medical history was admitted on March 18, 2020, presenting since 3 days asthenia, abdominal pain, and dry cough but no fever. Adenomegalies, splenomegaly, leukocytosis, and elevated LDH suggested mature lymphoproliferation. Considering the current health context, an RT-PCR testing for COVID-19 (coronavirus disease 2019) was performed and found to be positive. Early chest CT showed no sign of pulmonary infection but multiple adenomegalies. An F-FDG PET/CT performed 5 days later to assess the extent of the hemopathy revealed the apparition of FDG-avid bilateral ground glass and subpleural curvilinear opacities suggesting COVID-19-associated pneumopathy.

Topics & Concepts

MedicineLeukocytosisCoronavirus disease 2019 (COVID-19)Context (archaeology)LymphomaRadiologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Abdominal painPathologyDiseaseNuclear medicineInternal medicineInfectious disease (medical specialty)BiologyPaleontologyHematological disorders and diagnosticsCOVID-19 and healthcare impactsLong-Term Effects of COVID-19
FDG PET/CT in a Patient With Mantle Cell Lymphoma and COVID-19 | Litcius